Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,010 | -450 | -2,520 | -1,720 | -1,230 |
| Depreciation Amortization | 30 | 20 | 70 | 80 | 60 |
| Other Working Capital | 210 | 160 | 550 | 140 | -6 |
| Other Operating Activity | 110 | 60 | 230 | 90 | 96 |
| Operating Cash Flow | $-660 | $-210 | $-1,670 | $-1,410 | $-1,080 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -20 | -20 | -20 |
| Other Investing Activity | 0 | 0 | 40 | 25 | 40 |
| Investing Cash Flow | $-1 | $-1 | $20 | $5 | $20 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 550 | 120 | 1,500 | 1,050 | 760 |
| Financing Cash Flow | $550 | $120 | $1,500 | $1,050 | $760 |
| Beginning Cash Position | 210 | 210 | 360 | 360 | 360 |
| End Cash Position | 100 | 110 | 210 | 10 | 60 |
| Net Cash Flow | $-110 | $-90 | $-140 | $-350 | $-300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -660 | -210 | -1,670 | -1,410 | -1,080 |
| Free Cash Flow | -660 | -210 | -1,670 | -1,410 | -1,080 |